Physician profile
Robert Brown
NPI 1760907208
$1,634.18
in general payments reported to CMS, 2019-2025
18 companies · $39.55 in 2025
The $39.55 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $323 · 2022: $323 · 2023: $787 · 2024: $161 · 2025: $39.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $987.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $371.21 | 2021-2023 | Impella |
| E.R. Squibb & Sons, L.L.C. | $305.78 | 2022-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $169.08 | 2021-2023 | |
| Atricure, INC. | $125.82 | 2023 | |
| Abbott Laboratories | $101.42 | 2021-2023 | Cardiomems |
| Boston Scientific Corporation | $92.47 | 2022-2023 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Janssen Pharmaceuticals, INC | $90.23 | 2023-2024 | Xarelto |
| Pfizer INC. | $71.68 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $63.69 | 2022-2023 | |
| Amgen INC. | $46.25 | 2022-2023 | Repatha |
| Inspire Medical Systems, INC. | $37.58 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.42 | 2022 | |
| Merck Sharp & Dohme LLC | $31.70 | 2022-2024 | Verquvo |
| Vapotherm INC | $25.46 | 2025 | Vapotherm |
| Novo Nordisk INC | $17.91 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $16.48 | 2022 | |
| Irhythm Technologies, INC. | $16.07 | 2024 | Zio Xt Patch, Zio Monitor |
| Esperion Therapeutics, INC. | $13.93 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.